Avanos Medical, Inc.
AVNS
$11.36
-$0.07-0.61%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.48% | -6.74% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.48% | -6.74% | |||
| Cost of Revenue | 6.69% | -4.78% | |||
| Gross Profit | 2.56% | -8.37% | |||
| SG&A Expenses | 10.30% | -21.15% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 118.75% | -223.08% | |||
| Total Operating Expenses | 9.73% | -7.96% | |||
| Operating Income | -75.73% | 17.05% | |||
| Income Before Tax | -882.47% | 102.31% | |||
| Income Tax Expenses | -70.97% | 113.19% | |||
| Earnings from Continuing Operations | -1,263.64% | 101.66% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -1,263.64% | 101.66% | |||
| EBIT | -75.73% | 17.05% | |||
| EBITDA | -37.19% | 0.00% | |||
| EPS Basic | -1,258.31% | 101.66% | |||
| Normalized Basic EPS | -88.75% | 42.32% | |||
| EPS Diluted | -1,285.71% | 101.62% | |||
| Normalized Diluted EPS | -88.57% | 40.15% | |||
| Average Basic Shares Outstanding | 0.43% | 0.22% | |||
| Average Diluted Shares Outstanding | -1.07% | 1.74% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||